CASI Pharmaceuticals, Inc (DE)
CASIDelisted- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000895051
CASI Pharmaceuticals, Inc (DE) was delisted in 2023; its insiders filed their last Form 4 on Sep 9, 2022; 23 institutions reported holding it in 13F filings for Q4 2022, worth $3.31M in total; no superinvestor held it.
Q2 2021 vs. Q1 2021
How the institutions holding CASI Pharmaceuticals, Inc (DE) changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 86 | 69 | −17 |
| Shares | 53.1M | 46.7M | −6.41M (−12.1%) |
| Value | $127.4M | $72.3M | −$55.1M (−43.2%) |
New holders (17)
Institutions that held CASI Pharmaceuticals, Inc (DE) at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ergoteles LLC | 300,400 | $466.0K | 0.01% |
| Marshall Wace, LLP | 223,709 | $347.0K | 0.00% |
| Tibra Equities Europe Ltd | 216,300 | $335.0K | 0.10% |
| HRT Financial LP | 152,730 | $236.0K | 0.00% |
| Jane Street Group, LLC | 53,424 | $83.0K | 0.00% |
| ExodusPoint Capital Management, LP | 46,041 | $71.0K | 0.00% |
| Bailard, Inc. | 40,400 | $63.0K | 0.00% |
| Sterneck Capital Management, LLC | 40,000 | $47.0K | 0.03% |
| LMR Partners LLP | 30,360 | $47.0K | 0.00% |
| Schonfeld Strategic Advisors LLC | 20,600 | $32.0K | 0.00% |
| Mosaic Family Wealth, LLC | 17,500 | $27.0K | 0.01% |
| Prudential Financial Inc | 16,600 | $26.0K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 16,246 | $25.0K | 0.01% |
| Manatuck Hill Partners, LLC | 15,090 | $23.0K | 0.01% |
| Alpine Global Management, LLC | 11,532 | $18.0K | 0.00% |
| Advisory Services Network, LLC | 7,000 | $11.0K | 0.00% |
| Quadrant Capital Group LLC | 266 | $0 | 0.00% |
Sold out (34)
Institutions that held CASI Pharmaceuticals, Inc (DE) at the end of Q1 2021 and filed for Q2 2021 without it.